Spotlight on Clinical Response Activity of dasatinib against L576P KIT mutant melanoma: Molecular, cellular, and clinical correlates

Abstract

Point mutations in the KIT receptor tyrosine kinase gene have recently been identified in mucosal, acral lentiginous, and chronically sun-damaged melanomas. We have identified the first human melanoma cell line with an endogenous L576P mutation, the most common KIT mutation in melanoma ( 30-40%). In vitro testing showed that the cell viability of the L576P… (More)

Topics

4 Figures and Tables

Slides referencing similar topics